Floatz logo

Dociparstat

MDS

Washington University School of Medicineother_biologicalPhase 1Dormant
CC
40/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
27/ 100
Competitive Position
81/ 100

Competitive context

29 Active assets in the MDS cohort.

Asset / SponsorPhaseRating
Solu-Cortef
Andrew E. Place, MD
Phase 3BB
Equine Atg
DKMS gemeinnützige GmbH
Phase 3BB
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
Fred Hutchinson Cancer Center
Phase 2/3BB
Guadecitabine
Groupe Francophone des Myelodysplasies
Phase 2BB
Benadryl
M.D. Anderson Cancer Center
Phase 2BB

View all 47 →

Same molecule, other indications

Dociparstat is also rated in:

acute myeloid leukemiaDormant
CCC
Indicative ·
51 / 100
View asset →
malignant pancreatic neoplasmDormant
CC
Indicative ·
46 / 100
View asset →
cancerDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →